Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,131 INR | +2.53% | +4.07% | +4.36% |
Sales 2024 * | 287B 3.44B | Sales 2025 * | 314B 3.77B | Capitalization | 663B 7.95B |
---|---|---|---|---|---|
Net income 2024 * | 31.44B 377M | Net income 2025 * | 37.86B 454M | EV / Sales 2024 * | 2.25 x |
Net cash position 2024 * | 18.34B 220M | Net cash position 2025 * | 35.81B 429M | EV / Sales 2025 * | 1.99 x |
P/E ratio 2024 * |
21.2
x | P/E ratio 2025 * |
17.4
x | Employees | 23,451 |
Yield 2024 * |
0.36% | Yield 2025 * |
0.44% | Free-Float | 47.93% |
Latest transcript on Aurobindo Pharma
1 day | +2.53% | ||
1 week | +4.07% | ||
Current month | +3.91% | ||
1 month | +7.43% | ||
3 months | -1.70% | ||
6 months | +32.46% | ||
Current year | +4.36% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 86-12-25 | |
Director of Finance/CFO | - | 12-12-31 | |
B. Adi Reddy
CMP | Compliance Officer | - | 16-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 66 | 86-12-25 | |
Founder | 66 | 86-12-25 | |
Director/Board Member | 64 | 03-05-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.32% | 6 M€ | +6.07% | - | |
0.22% | 18 M€ | +3.66% | ||
0.12% | 11 M€ | +1.79% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1,131 | +2.53% | 1,511,617 |
24-04-25 | 1,103 | +1.78% | 1,642,872 |
24-04-24 | 1,084 | -0.84% | 923,839 |
24-04-23 | 1,093 | +1.58% | 1,150,312 |
24-04-22 | 1,076 | -0.99% | 1,267,744 |
Delayed Quote NSE India S.E., April 26, 2024 at 07:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.36% | 7.95B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- AUROPHARMA Stock